Diagnostic and Interventional Cardiology

The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR

MedAlliance Announces Enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease ...

September 11, 2023

Regulatory and quality leader brings decades of global SaMD experience to guide leading AI-powered cardiovascular diagnostic company through growth and expansion

News | Cardiovascular Business

Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

September 11, 2023

the Company is exploring development of a new Phase III clinical trial protocol

News | Heart Failure

BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs

September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

September 08, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

MPROVE-ISCHEMIA, a randomized, placebo-controlled trial, with topline data expected in 4Q 2023

News | Cardiovascular Clinical Studies

Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISCHEMIA Clinical Trial of Ninerafaxstat in Patients with Stable Angina

September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...

September 08, 2023

Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically actionable variants in DCM genes than those of European ancestry

News | Cardiovascular Clinical Studies

Study Highlights Need for Diversity in Clinical Trials to Better Understand, Treat Inherited Heart Muscle Disease

September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...

September 08, 2023

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety

News | Left Atrial Appendage (LAA) Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...

September 07, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council

News | Hypertension

Faulkner to be Honored by American Heart Association

September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...

September 07, 2023

Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension

News | Artificial Intelligence

Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms

September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that ...

September 07, 2023

Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap, which were designed to improve ablation outcomes and procedural efficiencies.

News | Artificial Intelligence

Vektor Medical Announces Enhanced AI-based vMap for Improved Cardiac Ablation Outcomes, Non-Invasive Mapping of Cardiac Arrhythmias

September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

September 07, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Annual Scientific Symposium will take place October 23-26 in San Francisco

Feature | TCT

CRF Announces TCT 2023 Late-breaking Clinical Trials

September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical ...

September 06, 2023

The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows

News | Structural Heart

Large Kaiser Permanente Study Could Lead to Better Management for Patients with Aortic Stenosis

September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser ...

September 06, 2023

Updated AI-based software is designed to improve cardiac ablation outcomes and procedural efficiencies

News | ECG

Vektor Medical Unveils Enhanced vMap Technology for Accurate, Non-invasive Mapping of Cardiac Arrhythmias

September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

September 06, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.

News | Cardiovascular Clinical Studies

Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump

September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...

September 06, 2023

GE HealthCare and Mass General Brigham have announced the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity.

News | Artificial Intelligence

Mass Gen Brigham and GE HealthCare Collaboration Announces AI Algorithm, Radiology Operations Module (ROM), to Optimize Scheduling and Productivity

September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co ...

September 06, 2023

Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.

News | Cardiovascular Clinical Studies

Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...

September 05, 2023